Natriumchlorid Aptapharma (Sodium Chloride)

Sodium Chloride, the active ingredient in Natriumchlorid Aptapharma, is an electrolyte presented as an injection solution for intravenous use. It is employed to restore extracellular fluid volume and correct electrolyte imbalances in patients who require fluid replacement, such as those suffering from dehydration or hypovolemia.

GNH USA supplies Natriumchlorid Aptapharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and healthcare institutions worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, including temperature‑controlled shipping where required.

Natriumchlorid Aptapharma, an intravenous electrolyte solution, is used in clinical situations that require restoration of fluid and electrolyte balance. - Fluid replacement: restores intravascular volume and corrects sodium and chloride deficits. - Dehydration: rehydrates patients and normalizes serum sodium concentrations. - Hypovolemia: increases circulating blood volume to improve tissue perfusion.

Intravenous administration of sodium chloride may be associated with the following adverse reactions.

Common Side Effects: - Injection site pain: mild discomfort or tenderness at the infusion site. - Phlebitis: inflammation of the vein used for administration. - Hypernatremia: elevated serum sodium if administered excessively. - Fluid overload: signs of excess volume such as peripheral edema.

Serious or Rare Side Effects: - Severe hypernatremia: can lead to neurological disturbances. - Pulmonary edema: accumulation of fluid in the lungs impairing breathing. - Anaphylactic reaction: sudden severe allergic response requiring emergency care. - Cardiac arrhythmia: abnormal heart rhythm due to electrolyte imbalance.

Before using Natriumchlorid Aptapharma, clinicians should consider several safety measures. - Assess electrolyte status: verify baseline sodium and chloride levels. - Monitor fluid balance: track input and output during infusion. - Adjust dose in renal impairment: reduce volume in patients with decreased kidney function. - Use caution in heart failure: avoid excessive volume that may worsen congestion. - Avoid rapid infusion in neonates: administer at recommended rate to prevent circulatory overload. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Sodium chloride infusion can interact with other medications, influencing fluid and electrolyte homeostasis.

Major Interactions (Avoid): - Concurrent hypertonic saline: may cause dangerous hypernatremia. - Potassium chloride IV: risk of severe electrolyte disturbances. - Loop diuretics: can exacerbate sodium loss leading to imbalance.

Moderate Interactions (Monitor Closely): - NSAIDs: may impair renal function affecting sodium handling. - ACE inhibitors or ARBs: can alter fluid retention and potassium levels. - Corticosteroids: increase sodium retention, requiring monitoring.